Citation: Q. Zhou et al., Cyclin D1 in breast premalignancy and early breast cancer: implications for prevention and treatment, CANCER LETT, 162(1), 2001, pp. 3-17
Authors:
Hartsough, MT
Clare, SE
Mair, M
Elkahloun, AG
Sgroi, D
Osborne, CK
Clark, G
Steeg, PS
Citation: Mt. Hartsough et al., Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition, CANCER RES, 61(5), 2001, pp. 2320-2327
Citation: Ps. Steeg, Molecular biology of breast cancer metastasis - 'Has it spread?': disarming one of the most terrifying questions, BREAST CA R, 2(6), 2000, pp. 396-399
Citation: Dr. Welch et al., Molecular biology of breast cancer metastasis - Genetic regulation of human breast carcinoma metastasis, BREAST CA R, 2(6), 2000, pp. 408-416
Authors:
Zhou, Q
Wulfkuhle, J
Ouatas, T
Fukushima, P
Stetler-Stevenson, M
Miller, FR
Steeg, PS
Citation: Q. Zhou et al., Cyclin D1 overexpression in a model of human breast premalignancy: preferential stimulation of anchorage-independent but not anchorage-dependent growth is associated with increased cdk2 activity, BREAST CANC, 59(1), 2000, pp. 27-39
Authors:
Zhou, Q
Fukushima, P
DeGraff, W
Mitchell, JB
Stetler-Stevenson, M
Ashkenazi, A
Steeg, PS
Citation: Q. Zhou et al., Radiation and the Apo2L/TRAIL apoptotic pathway preferentially inhibit thecolonization of premalignant human breast cells overexpressing cyclin D1, CANCER RES, 60(10), 2000, pp. 2611-2615
Citation: Ads. Otero et al., Wild-type NM23-H1, but not its S120 mutants, suppresses desensitization ofmuscarinic potassium current, BBA-MOL CEL, 1449(2), 1999, pp. 157-168